Statement on Human Challenge Studies for COVID-19 Vaccine Development
Statement / Press • 2020Two recent developments have brought renewed publicity to proposals to conduct human challenge studies to test COVID-19 vaccine candidates: an open letter from the organization 1DaySooner and media reports that Adrian Hill’s Oxford University research group is planning a challenge study, taking advantage of the lack of regulatory oversight of human challenge experiments in the United Kingdom.
Sanofi Withdraws Two Patent Applications on Life-Saving Tuberculosis Prevention Drugs in Europe and in Indonesia
Statement / Press • 2020Follow up to our 12/19 statement applauding Indian activists for taking legal action to oppose two patent applications filed by Sanofi in India. This joint statement from Treatment Action Group and OTMeds urges Sanofi to deliver on its promise to withdraw in all countries where the applications were filed and are still pending.
TAG Testimony to NY City Council on Plan for COVID-19 Testing and Contact Tracing
Webinars • 2020On May 15, TAG Executive Director Mark Harrington presented this testimony to the New York City Council Committee on and Health and the New York Council Committee on Hospitals on Oversight: NYC's Plan for COVID-19 Testing and Contact Tracing.
Treatment Action Group Statement on HIV Treatments and SARS-CoV-2/COVID-19
Statement / Press • 2020Treatment Action Group (TAG) is urging caution regarding the use of antiretroviral (ART) drugs as treatments for SARS-CoV-2/COVID-19. While there is clearly an acute need to carefully and quickly study interventions that may have activity against SARS-CoV-2, the virus which causes COVID-19 disease, it’s vitally important to be aware of the information that is currently available.
Guide de l’activists pour les Diagnostics du Virus de l’Hepatite C (French, also available for assisted technology)
PDF • 2019Juego completo de sábanas 2015-2017 VHC informativas en español en formato PDF
PDF • 2019Spanish group v4.pdf
Treatment Action Group Applauds Progress on Ending HIV in New York, Cautions Against Complacency
Statement / Press • 2019Treatment Action Group (TAG) applauds progress in New York towards ending HIV as an epidemic, with record decreases in estimated statewide and citywide HIV incidence in 2018. TAG states that accelerating impact at the community level will be critical to reach the Ending the Epidemic 2020 targets.
Protestors Demand Cepheid Halve the Price of GeneXpert TB Tests to US$5
Statement / Press • 2019The high cost of GeneXpert tests for tuberculosis (TB) leaves open a critical gap in the diagnosis of TB and fails to consider volume of sales and public investments in the development of GeneXpert.
Letter from Health Organizations: NAFTA Renegotiations Must Not Undermine Access to Affordable Medicines
Letters • 2018A group of 97 International, U.S., Canadian, and Mexican health organizations sent this letter to representatives of those countries, asking them to ensure that any North American Free Trade Agreement (NAFTA) renegotiations don’t undermine access to affordable medicines.
Fierce Activism from the Global Access to Medicines (A2M) Movement: Reflections on Recent Sucess
TAGline • 2018By Bryn Gay, HCV Project Director, TAG Access to medicines (A2M) activists have become better coordinated, articulate, and adept in responding to pharmaceutical industry shenanigans that threaten access to affordable medicines since the establishment of harmonized global intellectual property (IP) legislation under the initial 1995 Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), TRIPS-plus…